Zhang Rui, Mai Yongjian, Ye Huijing, Lian Xiufen, Yang Huasheng, Zhu Yanling, Gan Xiaoliang
Department of Anesthesiology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, 510060, People's Republic of China.
Department of Orbital Diseases and Ocular Oncology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, 510060, People's Republic of China.
J Pain Res. 2024 Nov 11;17:3707-3717. doi: 10.2147/JPR.S491994. eCollection 2024.
Opioid-minimizing strategies are making their appearance in enhanced recovery after surgery. This study is aimed to explore the potential advantages of opioid-free analgesia (OFA) compared to opioid-sparing analgesia (OSA) in patients undergoing orbital fracture reconstruction.
In this prospective, single-center, randomized controlled study, we randomly recruited 122 patients undergoing orbital fracture reconstruction under general anesthesia. Patients received total intravenous anesthesia with a flexible laryngeal mask airway, and multimodal analgesia with either OSA or OFA methods. The OSA group (n = 61) received low doses of fentanyl and nonsteroidal anti-inflammatory drugs (NSAIDs), and the OFA group (n = 61) received medial canthus peribulbar block (MCPB) combined with NSAIDs. The primary outcomes consisted of area-under-the-curve (AUC) of the numerical rating scale (NRS) pain score, and the incidence of postoperative nausea and vomiting (PONV) through the first 24h.
Compared to the OSA group, the OFA group demonstrated non-inferiority in postoperative analgesia through the first 24 postoperative hours (difference of the medians, -6; 95% confidence interval [CI], -12 to 6), but failed to meet the non-inferiority criterion in the incidence of PONV (difference ratio, 3%; 95% CI, -7% to 14%). The Quality of Recovery-40 questionnaire (QoR-40) scores on postoperative day 1 was significantly higher in group OFA compared to group OSA (188 [178 to 196] vs 181 [169 to 191], respectively; = 0.005).
In orbital fracture reconstruction, both OFA and OSA strategies provide effective postoperative pain relief, but OFA using MCPB combined NSAIDs enhances the quality of early postoperative recovery.
Chinese Clinical Trial Registry ChiCTR1900028088.
减少阿片类药物的策略正在出现在术后加速康复中。本研究旨在探讨在接受眼眶骨折重建的患者中,与保留阿片类药物镇痛(OSA)相比,无阿片类药物镇痛(OFA)的潜在优势。
在这项前瞻性、单中心、随机对照研究中,我们随机招募了122例在全身麻醉下接受眼眶骨折重建的患者。患者采用喉罩气道进行全静脉麻醉,并采用OSA或OFA方法进行多模式镇痛。OSA组(n = 61)接受低剂量芬太尼和非甾体类抗炎药(NSAIDs),OFA组(n = 61)接受内眦球周阻滞(MCPB)联合NSAIDs。主要结局包括数字评分量表(NRS)疼痛评分的曲线下面积(AUC)以及术后24小时内术后恶心呕吐(PONV)的发生率。
与OSA组相比,OFA组在术后24小时内的术后镇痛方面显示出非劣效性(中位数差异,-6;95%置信区间[CI],-12至6),但在PONV发生率方面未达到非劣效性标准(差异率,3%;95%CI,-7%至14%)。与OSA组相比,OFA组术后第1天的恢复质量-40问卷(QoR-40)评分显著更高(分别为188[178至196]和181[169至191];P = 0.005)。
在眼眶骨折重建中,OFA和OSA策略均能有效缓解术后疼痛,但使用MCPB联合NSAIDs的OFA可提高术后早期恢复质量。
中国临床试验注册中心ChiCTR1900028088